Richard Ssekitoleko1, Moses R Kamya2, Arthur L Reingold3. 1. School of Public Health, University of California, Berkeley 50 University Hall, 7360 Berkeley, CA 94720, USA ; Department of Medicine Makerere University College of Health Sciences, PO Box 7072, Kampala, Uganda. 2. Department of Medicine Makerere University College of Health Sciences, PO Box 7072, Kampala, Uganda. 3. School of Public Health, University of California, Berkeley 50 University Hall, 7360 Berkeley, CA 94720, USA.
Abstract
AIM: To determine the role of primary antifungal prophylaxis in the prevention of cryptococcal meningitis and all-cause mortality in advanced HIV infection. MATERIALS & METHODS: This was a systematic review and meta-analysis of randomized trials and observational studies. Google Scholar™, PubMed and Embase databases were searched for relevant studies. Quality was assessed using different criteria, depending on study type. Publication bias was assessed and subgroup and sensitivity analyses were performed. When the results of the meta-analysis were homogeneous, the fixed-effects model was used; when the results of the meta-analysis were heterogenous, the random effects model was used. RESULTS: Primary prophylaxis prevented cryptococcal meningitis but did not confer protection against overall mortality, although there was evidence of a reduction in cryptococcal-specific mortality in resource-limited settings. CONCLUSION: Primary antifungal prophylaxis should be recommended in patients with advanced HIV infection in resource-limited settings with a high incidence of cryptococcal meningitis.
AIM: To determine the role of primary antifungal prophylaxis in the prevention of cryptococcal meningitis and all-cause mortality in advanced HIV infection. MATERIALS & METHODS: This was a systematic review and meta-analysis of randomized trials and observational studies. Google Scholar™, PubMed and Embase databases were searched for relevant studies. Quality was assessed using different criteria, depending on study type. Publication bias was assessed and subgroup and sensitivity analyses were performed. When the results of the meta-analysis were homogeneous, the fixed-effects model was used; when the results of the meta-analysis were heterogenous, the random effects model was used. RESULTS: Primary prophylaxis prevented cryptococcal meningitis but did not confer protection against overall mortality, although there was evidence of a reduction in cryptococcal-specific mortality in resource-limited settings. CONCLUSION: Primary antifungal prophylaxis should be recommended in patients with advanced HIV infection in resource-limited settings with a high incidence of cryptococcal meningitis.
Entities:
Keywords:
advanced HIV infection; all-cause mortality; cryptococcal meningitis; fluconazole; itraconazole; prevention of cryptococcal meningitis; primary antifungal prophylaxis; resource-limited settings
Authors: C Pradier; E Bernard; C Lubick; M Toussaint-Gari; Y Pinier; J Durant; V Mondain; Y Le Fichoux; P Dellamonica Journal: J Infect Dis Date: 1992-04 Impact factor: 5.226
Authors: D S McKinsey; L J Wheat; G A Cloud; M Pierce; J R Black; D M Bamberger; M Goldman; C J Thomas; H M Gutsch; B Moskovitz; W E Dismukes; C A Kauffman Journal: Clin Infect Dis Date: 1999-05 Impact factor: 9.079
Authors: David B Meya; Yukari C Manabe; Barbara Castelnuovo; Bethany A Cook; Ali M Elbireer; Andrew Kambugu; Moses R Kamya; Paul R Bohjanen; David R Boulware Journal: Clin Infect Dis Date: 2010-08-15 Impact factor: 9.079
Authors: D E Smith; J Bell; M Johnson; M Youle; B Gazzard; S Tchamouroff; G Frechette; W Schlech; S Miller; D Spencer; W Seifert; M Peeters; K De Beule Journal: HIV Med Date: 2001-04 Impact factor: 3.180
Authors: John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell Journal: Clin Infect Dis Date: 2010-02-01 Impact factor: 9.079
Authors: S A Bozzette; R A Larsen; J Chiu; M A Leal; J Jacobsen; P Rothman; P Robinson; G Gilbert; J A McCutchan; J Tilles Journal: N Engl J Med Date: 1991-02-28 Impact factor: 91.245
Authors: Ajibola A Awotiwon; Samuel Johnson; George W Rutherford; Graeme Meintjes; Ingrid Eshun-Wilson Journal: Cochrane Database Syst Rev Date: 2018-08-29
Authors: Daniel B Chastain; Andrés F Henao-Martínez; Austin C Dykes; Gregory M Steele; Laura Leigh Stoudenmire; Geren M Thomas; Vanessa Kung; Carlos Franco-Paredes Journal: Ther Adv Infect Dis Date: 2022-01-15